Women's Health MRI

Validating a prognostic scoring system for locoregional recurrence risk in post-mastectomy patients with varying levels of axillary lymph node involvement, emerging research suggests patients with intermediate risk for breast cancer recurrence could benefit from post-mastectomy radiotherapy.

Review top radiology content from the week.

Boston Scientific’s STIMVIEW XT reportedly enables 3D brain imaging that facilitates more accurate lead placement and targeted stimulation modeling for patients with Parkinson’s disease or essential tremor.

In a recent video interview, Arun Krishnaraj, MD, MPH and David Larson, MD, MBA, discussed the continued use of physical media to transport medical images between different health-care facilities, resulting inefficiencies and delays with patient care, and the initiative to create a linked multi-hub model to end this dated practice once and for all.

Review top radiology content from the week.

Review top radiology content from the week.

Review top radiology content from the week.

Utilizing biomarkers from magnetic resonance imaging (MRI) exams, AMRA Medical’s BCP Scan reportedly provides precise measurements of muscle and fat.

In a new study comparing the development of myocarditis among vaccinated patients to those with COVID-19-related illness and patients with other etiologies, researchers noted less severe abnormalities on magnetic resonance imaging (MRI) and no major adverse events in a short-term follow-up.

The new whole-body magnetic resonance imaging (MRI) platform reportedly offers enhanced image quality and increased patient comfort.

Given the broad range of fibrocystic changes, the authors of a recent study suggest that more precise diagnosis of breast MRIs could significantly reduce unnecessary biopsy procedures.

A new meta-analysis examines the diagnostic benefit of this emerging complementary modality.

Diffusion-weighted imaging may be useful as a safe and effective screening tool to supplement mammography in women with dense breast tissues.

Following breast cancer treatment, women who have access to breast MRI may safely forgo additional mammographic or digital breast tomosynthesis follow-up.

Artificial intelligence can help seek out and identify high-risk patients who might benefit from more extensive screening.

Nonsuppressed background parenchymal enhancement could indicate patients who will show inferior response and allow for a personalized redirection of treatment.

Looking for these features could reduce biopsies and facilitate more timely screening.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Images can detect non-mass enhancement extension that correlates to tumor involvement of the nipple.

Primary care providers are less likely to recommend breast MRI for screening high-risk women.

Breast MRI is a good tool for supplemental screening in women who have a personal history of breast cancer.

Meg Eckenroad, Hologic’s vice president of women’s health, discusses the motivation and goals of the new $20-million Project Health Equality.

Dana Bonaminio, M.D., Women’s Imaging National Subspecialty Lead from Radiology Partners, offers tips and guidance on what providers should make sure women know about their breast health.

Tattoo ink can migrate in female patients, potentially mimicking lymph node findings on breast imaging.

MD Anderson Cancer Center medical director shares her thoughts the priorities and challenges facing breast cancer detection and screening.

Patients want to know their risk. But, before you provide it, consider these factors to successfully integrate it into your practice.

Here's what to expect this week on Diagnostic Imaging.

Patients indicated breast imaging radiologists expressed more empathy over the diagnosis and had more understanding of their scans than other providers.

CEM performance showed no significant difference between women with or without breast implants, and it produced very few complications.

Despite recommendations from the American College of Radiology, most providers opt to delay screening in these women.